0001415889-22-012508.txt : 20221213
0001415889-22-012508.hdr.sgml : 20221213
20221213180012
ACCESSION NUMBER: 0001415889-22-012508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221209
FILED AS OF DATE: 20221213
DATE AS OF CHANGE: 20221213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eldridge George A
CENTRAL INDEX KEY: 0001413006
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40544
FILM NUMBER: 221460674
MAIL ADDRESS:
STREET 1: C/O TARGANTA THERAPEUTICS CORPORATION
STREET 2: 222 THIRD STREET SUITE 2300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-443-2400
MAIL ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-12132022_061201.xml
X0306
4
2022-12-09
0001798749
Aerovate Therapeutics, Inc.
AVTE
0001413006
Eldridge George A
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM
MA
02451
false
true
false
false
SEE REMARKS
Common Stock
2022-12-09
4
M
0
3969
2.14
A
5929
D
Common Stock
2022-12-09
4
S
0
3386
24.2335
D
2543
D
Common Stock
2022-12-09
4
S
0
583
25.2327
D
1960
D
Common Stock
2022-12-12
4
M
0
10000
2.14
A
11960
D
Common Stock
2022-12-12
4
S
0
10000
30.0428
D
1960
D
Stock Option (Right to Buy)
2.14
2022-12-09
4
M
0
3969
0
D
2031-04-01
Common Stock
3969
36757
D
Stock Option (Right to Buy)
2.14
2022-12-12
4
M
0
7094
0
D
2031-04-01
Common Stock
7094
29663
D
Stock Option (Right to Buy)
2.14
2022-12-12
4
M
0
2906
0
D
2031-04-01
Common Stock
2906
79863
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $25.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.41, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.39, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Officer Title: Chief Financial Officer and Treasurer
/s/ George A. Eldridge
2022-12-13